Keratinocyte-Conditioned Media Regulate Collagen Expression in Dermal Fibroblasts  by Ghaffari, Abdi et al.
Keratinocyte-Conditioned Media Regulate Collagen
Expression in Dermal Fibroblasts
Abdi Ghaffari1,2, Ruhangiz T. Kilani1,2 and Aziz Ghahary1
Excessive extracellular matrix (ECM) production during dermal wound healing often leads to fibrotic conditions
such as keloids and hypertrophic scarring (HSc). Type I collagen is the predominant form of collagen in the
human skin and is produced mainly by dermal fibroblasts. It has been suggested that abnormalities in
epidermal–dermal interaction can lead to excessive production of collagen by fibroblasts. To identify and
further characterize any possible keratinocyte-derived collagen-inhibitory factors (KD-CIFs), we investigated the
expression of pro-a1(I) collagen at the level of mRNA and protein in human fibroblasts that had been either co-
cultured with keratinocytes or treated with keratinocyte-conditioned medium (KCM). Fibroblasts in both
groups demonstrated a significant reduction in the steady-state levels of collagen mRNA and protein. Further
characterization of KD-CIFs revealed a high-molecular-weight factor (430 kDa) that showed stable activity at
high temperature (561C) and acidic pH (pH 2). Keratinocyte differentiation did not alter the release of KD-CIFs
into KCM. These results provide further evidence that type I collagen expression and synthesis in fibroblasts are
regulated by a keratinocyte-releasable factor(s) with an apparent molecular weight between 30 and 50 kDa.
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INTRODUCTION
The production of extracellular matrix (ECM) in response to
injury is desirable, and its timely cessation is also an essential
part of the normal healing process. Excessive ECM production
often leads to deleterious fibrotic conditions such as
hypertrophic scarring (HSc) and keloids in the skin (Scott
et al., 2000). Type I collagen is the predominant form of
collagen in the human skin and is produced mainly by
dermal fibroblasts (Cutroneo, 2003). Transcription of the
genes encoding both collagen a1(I) and a2(I) chains has
shown significant increase in severe fibrotic conditions (Uitto
et al., 1979; Ghahary et al., 1996). An increasing body of
evidence shows that the epidermal–mesenchymal interaction
during wound healing has a key function in controlling the
expression of ECM components, including type I collagen by
dermal cells. It is well established that any delay in re-
epithelialization by keratinocytes increases the frequency of
developing fibrotic conditions in the skin (Deitch et al.,
1983). Werner et al. (1994) reported that the inhibition of
keratinocyte growth factor receptor signaling reduced the
proliferation rate of epidermal keratinocytes at the wound
edge, leading to dermal hyper-thickening and fibrosis in
transgenic mice. In a clinical setting, the application of
cultured epithelial autografts and split-thickness skin grafts
has resulted in significant decreases in HSc formation
(Rudolph and Klein, 1973; Wood and Stoner, 1996).
With minimal direct cell-to-cell contact, keratinocyte–
fibroblast communication is regulated mainly by releasable
factors acting in an autocrine/paracrine loop. In fact, several
studies have demonstrated the regulatory role of releasable
factors within keratinocyte-conditioned medium (KCM) in the
expression of ECM genes in dermal fibroblasts (Ralston et al.,
1997; Nowinski et al., 2004; Harrison et al., 2005; Ghaffari
et al., 2006). These studies suggest that after epithelialization,
the presence of keratinocytes directs fibroblasts to a
phenotype more suited to ECM remodeling than to synthesis
(Ghahary et al., 1995; Harrison et al., 2006). In a search for
keratinocyte-releasable antifibrogenic factors, our group has
recently identified stratifin as a potent mediator of matrix
metalloproteinase (MMP) expression in dermal fibroblasts
(Ghahary et al., 2004; Ghaffari et al., 2006). Other studies on
keratinocyte–fibroblast co-culture systems or KCM have also
identified tumor necrosis factor-a (TNF-a), IL-1a, and IL-1b as
mediators of MMPs in fibroblasts, confirming a potential role
for keratinocytes in the regulation of matrix degradation and
remodeling (Mackay et al., 1992; Moon et al., 2002).
Fibroblasts harvested from keloid or HSc demonstrate
higher expression of collagen in culture (Ghahary et al.,
1993; Phan et al., 2002). Interestingly, normal fibroblasts also
show significant increases in collagen production in the
ORIGINAL ARTICLE
340 Journal of Investigative Dermatology (2009), Volume 129 & 2009 The Society for Investigative Dermatology
Received 13 July 2007; revised 26 June 2008; accepted 29 June 2008;
published online 11 September 2008
1Department of Surgery, BC Professional Firefighter’s Burn and Wound
Healing Research Lab, University of British Columbia, Vancouver, British
Columbia, Canada
Correspondence: Dr Aziz Ghahary, Department of Surgery, BC Professional
Firefighter’s Burn and Wound Healing Research Laboratory, University of
British Columbia, 344A JBRC, 2660 Oak Street, Vancouver, British Columbia,
Canada V6H 3Z6. E-mail: aghahary@interchange.ubc.ca
2These authors contributed equally to this work
Abbreviations: CTGF, connective tissue growth factor; ECM, extracellular
matrix; FBS, fetal bovine serum; HSc, hypertrophic scarring; KCM,
keratinocyte-conditioned medium; KD-CIFs, keratinocyte-derived collagen-
inhibitory factors; KSFM, keratinocyte serum-free medium; MMP, matrix
metalloproteinase; NCM, non-conditioned medium
presence of keloid- or HSc-derived keratinocytes (Lim et al.,
2002; Bellemare et al., 2005). However, co-culture studies
on the role of normal keratinocytes in fibroblast collagen
expression are somewhat controversial, demonstrating either
inhibition (Garner, 1998; Harrison et al., 2006) or upregula-
tion (Phan et al., 2002; Shephard et al., 2004; Bellemare
et al., 2005) of collagen synthesis. Although the nature of
collagen mediatory factors secreted by keratinocytes is not
well understood, it is clear that cellular communication at the
epidermal–dermal interface is important in the physiological
and pathological processes of dermal healing. To explore this
further, we have investigated the characteristics of potential
keratinocyte-derived collagen-inhibitory factors (KD-CIFs) in
a keratinocyte–fibroblast co-culture as well as in KCM by
monitoring type I collagen expression at both the mRNA and
the protein levels.
RESULTS
Keratinocyte-releasable factors inhibit collagen expression in
dermal fibroblasts in a co-culture system
We evaluated the steady-state level of type I collagen in
dermal fibroblasts in the presence or absence of keratinocytes
in a co-culture system. Keratinocytes (upper chamber) and
fibroblasts (lower chamber) were separated by a semi-
permeable membrane allowing the diffusion of macromole-
cules while preventing cell migration. As shown in Figure 1a,
a marked reduction in the steady-state level of type I collagen
mRNA (COL1A1) was observed in fibroblasts co-cultured
with keratinocytes (lane K/F) as compared with the fibro-
blast–fibroblast co-culture (lane F/F). As expected, a high
steady-state level of COL1A1 was observed in a fibroblast
monolayer cell culture (F). For control of total RNA loading
and quantitative analysis, all corresponding blots were re-
hybridized with a cDNA specific for 18S ribosomal RNA. The
signals were then quantified by densitometry, and the ratio of
COL1A1 mRNA/18S RNA was determined as shown in
Figure 1b. The finding clearly indicates a marked reduction in
the ratio of the steady-state level of type I collagen mRNA/
18S for fibroblasts co-cultured with keratinocytes relative to
fibroblast–fibroblast co-culture (F/F). A similar collagen-
inhibitory effect was also observed in a three-dimensional
skin substitute model, in which fibroblasts populated in a
bovine collagen lattice expressed lower levels of collagen
when keratinocytes were layered on the top of the lattice
(Figure 1c). To take into account the effect of keratinocytes on
fibroblast proliferation, we normalized the level of type I
procollagen measured in both conditioned media and cell
lysate against the cell number and observed similar reduc-
tions in the level of collagen per number of cells in each case
(data not shown).
KCM reduced the steady-state levels of collagen in dermal
fibroblasts in a time-dependent manner
The results of a time–response experiment revealed that KCM,
similar to keratinocyte co-culture, also reduced the steady-
state level of collagen mRNA in dermal fibroblasts after
24 hours of treatment (Figure 2a). The steady-state levels of
18S ribosomal RNA in the same samples were also evaluated
and used as a loading control. To determine whether changes
in mRNA are reflected at the level of protein translation, the
protein level of the a-1 chain of type I procollagen (pro-a1(I))
was evaluated by western blot using a specific antibody.
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Figure 1. Keratinocyte-releasable factor(s) reduces the expression of type I
collagen in dermal fibroblasts. (a) The levels of 4.8 and 5.8 kb transcripts of
pro-a1(I) collagen mRNA (COL1A1) in fibroblasts alone (F), fibroblasts co-
cultured with keratinocytes (K/F), and fibroblasts co-cultured with fibroblasts
(F/F) were evaluated by northern analysis. The same blot was re-hybridized for
18S ribosomal RNA and used as a control for RNA loading. The signals were
then quantified by densitometry and the ratio of COL1A1/18S was
determined. (b) The means of COL1A1/18S in K/F and F/F groups from two
separate experiments were calculated and are depicted as a histogram. (c)
COL1A1 mRNA expression in fibroblast-populated collagen gel was
evaluated in the presence of a keratinocyte (K/F) or a fibroblast (F/F) top layer.
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Figure 2. Collagen-inhibitory effect of KCM in dermal fibroblasts is time
dependent. (a) Fibroblasts were treated with KCM for 1, 3, 6, 12, 24, 36, or
48 hours. Total RNA was then extracted and subjected to northern analysis.
The blots were initially hybridized with cDNA specific for COL1A1 and
subsequently with cDNA for 18S ribosomal RNA used as a loading control. (b)
Similar time-dependent experiments in which fibroblasts were treated with
KCM for 12, 24, 36, and 48 hours, with control for 24 (C-24) and 48 (C-48)
hours. The level of intracellular type I procollagen protein was evaluated by
western blot using b-actin expression as a loading control. (c) For quantitative
analysis, this experiment was repeated four times, and the ratio of type I
collagen/b-actin (percentage of control, C-24) was calculated and the
mean±SD is depicted and shown here. *Po0.01 and **Po0.001 between
the control (C-24) and the cells treated with KCM for 36 and 48hours,
respectively.
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Considering the lag time between mRNA transcription and
protein translation, the reduction in the steady-state level of
pro-a1(I) collagen in 36 hours after KCM treatment was
consistent with the disappearance of the COL1A1 mRNA
signal at 24 hours. For quantitative analysis, the ratio of mean
±SD of type I collagen protein/b-actin (percentage of
control) was determined (Figure 2c). The results shown in
this panel revealed a significant reduction in the level of
collagen protein after 36 hours in KCM-treated cells
(49.2±9.28, n¼4, Po0.01) relative to the controls (C-24
and C-48). These findings indicate that the expression
and release of KD-CIFs by keratinocytes are independent of
a co-culture system, as KCM from monolayer keratinocytes
was also capable of reducing the steady-state levels of
collagen mRNA and protein in fibroblasts.
Molecular characteristics of KD-CIFs
To determine the approximate molecular weight of KD-CIFs,
we fractionated the total KCM collected every 48 hours up to
day 10 after differentiation. On fractionation of the KCM by
50 and 30 kDa centrifugal filters, the corresponding filtrate
and retentate were collected and analyzed for their collagen-
inhibitory activity in dermal fibroblasts with total KCM as the
positive control. As shown in Figure 3a, the steady-state
levels of type I collagen mRNA were markedly reduced in
fibroblasts treated with either total KCM (lane 1) or the filtrate
of the 50 kDa cutoff fraction (lane 3,o50 kDa) relative to the
retentate fraction (lane 2, 450 kDa). As a control, the non-
conditioned medium (NCM) was also processed as described
above, and the results showed no alteration in the steady-
state level of collagen mRNA in cells treated with either of
these fractions. To further narrow down the size of the KD-
CIFs in KCM, a 30 kDa cutoff filter was used in a second set of
experiments. The results shown in Figure 3b indicate that the
30 kDa cutoff filtrate (lane 3, o30 kDa) did not reduce the
steady-state level of collagen mRNA in fibroblasts. In
contrast, the level of collagen mRNA was significantly
(Po0.01) reduced in both the total KCM (lane 1) and the
30 kDa cutoff retentate (lane 2, 430 kDa) as compared with
that of fractionated NCM-treated cells used as negative
controls. These findings placed the apparent molecular
weight of the KD-CIFs between 30 and 50 kDa.
For quantitative analysis, the intensity of signals was
evaluated by densitometry, and the mean±SD of the steady-
state level of pro-a1(I) collagen mRNA/18S was plotted for
fibroblasts treated with nothing (C, control), total KCM
(KCM), 50 kDa retentate (450 kDa), 30–50 kDa fraction
(30–50), or 30 kDa filtrate (o30 kDa), as shown in Figure
3c. A significant reduction in the steady-state level of
collagen mRNA was seen in cells treated with either total
KCM (27.0±22.06, n¼4, Po0.001) or the fraction contain-
ing proteins with apparent molecular weight of 30–50 kDa
(47.0±12.7, n¼ 4, Po0.01) relative to NCM cells. The
results also revealed no significant difference in the steady-
state level of collagen mRNA between controls and cells
treated with either 450 or o30 kDa fractions of KCM. To
ensure that the reduction in the level of collagen is not caused
by the interruption of total protein synthesis, we also
evaluated and showed a marked increase in the steady-state
level of MMP-1 mRNA and protein in cells treated with KCM
(data not shown). The differential effect of KCM on collagen
and MMP-1 expressed by fibroblasts indicated the specificity
of matrix-modulating proteins present in KCM.
Stability of KD-CIFs
To characterize the stability of the factor(s) responsible for
collagen inhibition, KCM was subjected to acidification (pH
2) for 30minutes followed by neutralization (pH 7.4) with a
second sample heated at 56 1C for 30minutes. Dermal
fibroblasts were then incubated with the above samples for
24 (mRNA) and 48 hours (protein), and the steady-state levels
of collagen mRNA and protein expression were evaluated by
northern and western blot analyses, respectively. The results
shown in Figure 4a revealed a marked reduction in the
steady-state level of collagen mRNA in KCM-treated cells
(lane 1), and this activity was not affected by either
acidification/neutralization (lane 2) or heating of KCM at
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Figure 3. Crude determination of KD-CIF molecular weight. (a) KCM was
passed through a 50 kDa cutoff centrifugal filter, and corresponding filtrate
and retentate were used to treat dermal fibroblasts. Total KCM and non-
conditioned medium (NCM) were also used as positive and negative controls,
respectively. COL1A1 expression level was determined by northern blot
analysis. Total KCM (lane 1), retentate (lane 2,450 kDa), and filtrate (lane 3,
o50 kDa) of 50 kDa cutoff filter, as well as the same fractions for NCM, are
shown here. (b) The same experimental protocol as above but with a 30 kDa
cutoff filter. Total KCM (lane 1), retentate (lane 2,430 kDa), and filtrate (lane
3, o30 kDa) of 30 kDa cutoff filter and corresponding fractions of NCM are
presented. Expression of 18S ribosomal RNA was used as a control for
loading. (c) Graph represents the mean ratio of COL1A1/18S RNA (percentage
of control, which is NCM-treated cells)±SD of four separate experiments.
*Po0.01 and **Po0.001 between control and KCM or KCM fraction of
30–50 kDa treated cells, respectively.
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56 1C (lane 3). Consistent with COL1A1 mRNA, Figure 4b
revealed that pro-a1(I) collagen was also markedly reduced at
the protein level in fibroblasts treated with KCM (lane 1)
relative to the control (C). This reduction was more
pronounced in cells treated with either acidified/neutralized
(lane 2) or pre-heated (lane 3) KCM. For quantitative analysis,
the mean±SD of pro-a1(I) collagen/b-actin obtained from
three separate experiments was graphed (Figure 4b, lower
panel). Interestingly, the level of collagen protein was lower
in cells treated with acidified/neutralized (lane 2) or pre-
heated (lane 3) KCM relative to cells treated with untreated
KCM. This might be due to the fact that some collagen-
stimulating factors such as transforming growth factor-b1
(TGF-b1) in KCM, sensitive to both acidification and heat, are
deactivated at the same time.
To further characterize the KD-CIFs, the total KCM was
saturated with 80% ammonium sulfate to precipitate total
proteins in the conditioned medium. Precipitated proteins
were then used to treat fibroblasts. As seen in Figure 4c,
ammonium sulfate precipitation completely removed the
collagen-inhibitory activity of KCM in dermal fibroblasts
(lane PPT). The pattern of b-actin expression in the same
samples revealed that this blockage is neither due to protein
loading nor due to cytotoxicity of this treatment. In fact,
western blotting with anti-MMP-1 antibody revealed that the
MMP-1 stimulatory effect of KCM was not suppressed as a
result of ammonium sulfate precipitation (data not shown).
This finding confirmed that the loss of KD-CIF activity was not
due to total breakdown or deactivation of all protein
functional groups during ammonium sulfate precipitation.
Dialyzed supernatant from the same precipitation experiment
also failed to suppress collagen production in treated
fibroblasts, indicating that the collagen-inhibitory activity
was not retained in the supernatant fraction of KCM (data not
shown). For quantitative analysis, the mean±SD of pro-a1(I)
collagen protein/b-actin (percentage of control) from three
separate experiments was then calculated and graphed as
shown in Figure 4c, bottom panel.
Keratinocyte differentiation has no effect on KD-CIF activity
in fibroblasts
To investigate the effects of keratinocyte differentiation on the
release and activity of KD-CIFs, we collected KCM from
keratinocyte culture for up to 12 days. We made use of a
high-calcium test medium (49% keratinocyte serum-free
medium (KSFM)þ 49% DMEMþ 2% fetal bovine serum
(FBS)) to induce differentiation of cultured keratinocytes. As
keratinocytes differentiate, cells start to migrate on top of one
another, forming a multilayer cell culture in vitro (Figure 5a).
We further confirmed the differentiation by evaluating the
intracellular level of involucrin protein (Figure 5b), a marker
of keratinocyte differentiation. As seen in this panel, the
C 1 2 3
C 1 2 3
C 1 2 3
COL1A1
18S
Pro-α1(I)
β-Actin
Pro-α1(I)
β-Actin
*
*
*
*
Ty
pe
 1
co
lla
ge
n/
β-a
ct
in
(%
 of
 co
ntr
ol)
120
100
80
60
40
20
0
Ty
pe
 1
co
lla
ge
n/
β-a
ct
in
(%
 of
 co
ntr
ol) 10080
60
40
20
0
C PPTKCM
KCMC PPT
Figure 4. Stability of the keratinocyte-derived collagen-inhibitory factor(s).
(a) Dermal fibroblasts were treated with medium alone (lane C) or KCM that
had been collected and subjected to nothing (lane 1), acidification/
neutralization (lane 2), or heat at 56 1C for 30minutes (lane 3). Total RNA was
extracted after 24 hours and subjected to northern blot analysis for COL1A1
mRNA. The corresponding blots were subsequently re-hybridized with 18S
ribosomal RNA and used as a loading control. (b) In a similar set of
experiments, the levels of pro-a1(I) collagen protein and b-actin were
evaluated after 48 hours by western blot analysis. For quantitative analysis,
the mean±SD of pro-a1(I) collagen/b-actin obtained from three separate
experiments was then determined and the corresponding histogram is
depicted in the lower panel. *Po0.05, the significant difference between test
and control groups. (c) Cells were treated with nothing (C), KCM, or
ammonium sulfate-precipitated proteins from KCM (PTT). Total proteins were
extracted and evaluated for pro-a1(I) collagen protein and b-actin by western
blot analysis. The ratio of mean±SD of pro-a1(I) collagen/b-actin was then
determined from three different experiments, and the corresponding data are
depicted in the lower panel. *Po0.05, significant difference between test
(KCM) and control (C). No significant difference was observed between
control and PPT (P40.05).
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Figure 5. Keratinocyte differentiation has no effect on KD-CIF activity. (a)
The multilayer formation by differentiated keratinocytes on day 14 (right
panel) as compared with a monolayer of cells on day 0 (left panel). (b) Total
proteins from keratinocyte lysate after 0, 2, 4, 6, 8, 10, and 12 days of culture
were extracted and subjected to western blot analysis for involucrin protein
used as a marker of keratinocyte differentiation. The level of b-actin was
tested as a loading control. (c) Dermal fibroblasts were treated with KCM
collected on days 0, 4, 8, 10, and 12 of keratinocyte culture. Non-conditioned
medium was used as control (lane C). Total cell extracts were prepared and
intracellular type I procollagen and MMP-1 protein levels were determined by
western blot analysis. b-Actin is shown as loading control.
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expression of involucrin was easily detectable as early as 2
days after switching to a high-calcium medium and reached
its peak on day 10. To evaluate the collagen-suppressive
effect of conditioned media collected from un-differentiated
and differentiated cells, dermal fibroblasts were then treated
with total KCM collected from days 0, 4, 8, 10, and 12 for
48 hours. Western blot analysis revealed that all KCM
collections markedly reduced the expression levels of pro-
a1(I) collagen but not of b-actin in treated fibroblasts.
Therefore, keratinocyte differentiation did not alter synthesis,
release, or activity of KD-CIFs (Figure 5c). To ensure that the
reduction was not due to the interruption of total protein
synthesis in KCM-treated cells, the same samples were
evaluated for the expression of MMP-1. As shown in Figure
5c, in contrast to the collagen-inhibitory factors present in
KCM collected from differentiated cells, the stimulatory effect
of KCM on MMP-1 steadily increased as keratinocytes
differentiated.
DISCUSSION
Dermal fibrotic conditions, such as keloids and HSc, result in
bulky, itchy, and inelastic scars that pose serious health and
functional problems for recovering patients. The character-
istic excess ECM, which is of altered composition and
organization, is most likely the end product of a series of
events involving several cell types and cytokines released
during the process of healing (Scott et al., 2004). After an
injury, keratinocytes migrate and proliferate over the injured
site and exert paracrine effects on the underlying fibroblasts
(Werner et al., 2007). This study presents evidence for the
production of soluble KD-CIFs, independent of a paracrine
loop mechanism between keratinocytes and fibroblasts, with
stable activity at high temperature and low pH and an
estimated molecular size of 30–50 kDa. To characterize such
KD-CIFs for dermal fibroblasts, a keratinocyte/fibroblast co-
culture system was established to resemble the human skin,
in which these cells are separated by a porous basal
membrane. In a series of experiments, it was shown that
the steady-state level of pro-a1(I) collagen was significantly
suppressed in fibroblasts co-cultured with keratinocytes as
compared with fibroblasts co-cultured with fibroblasts. This
suppression was found at the levels of both mRNA and
protein. This concurs with data from Harrison et al. (2006)
and Garner (1998), in which the N-terminal propeptide of
type I collagen in conditioned medium or the incorporation
of [3H]proline was used as a marker for collagen production.
To ensure that the pro-a1(I) collagen-inhibitory effect of KCM
in fibroblasts was not caused by the suppression of protein
synthesis in these cells, the same samples collected from
treated fibroblasts were evaluated for MMP-1 expression. In
contrast to the inhibitory effect of KCM on pro-a1(I) collagen,
an increase in the levels of the MMP-1 mRNA and protein
was observed in the same fibroblasts. These findings are in
agreement with the clinical observations in which timely
epithelialization or the application of cultured epithelial
autografts significantly reduces the development of fibrosis in
injured skin tissue (Deitch et al., 1983; Wood and Stoner,
1996). These results further support the role of keratinocytes
in the regulation of fibroblasts into a phenotype more suitable
for ECM remodeling as compared with ECM deposition.
The range of growth factors or cytokines reported to be
expressed by keratinocytes, either constitutively or upon
stimulation, includes (IL)-1, -6, -7, -8, -10, -12, -15, -18, and -
20; TNF-a; IFN-a, -b, and -g (Grone, 2002); TGF-b1 (Ghahary
et al., 2001); and platelet-derived growth factor (PDGF)
(Ansel et al., 1993). Among these, IL-1a and IL-1b; TNF-a
(Mauviel et al., 1991; Diaz et al., 1993); and IFN-a, -b, and -g
(Granstein et al., 1990; Ghahary et al., 2000b; Ghosh et al.,
2006) have been reported to inhibit, directly or indirectly, the
expression of type I collagen in fibroblasts. It is important to
note that among these factors, only IL-1a was found in
measurable levels in KCM from primary keratinocytes
(Nowinski et al., 2002). In this study, we demonstrated the
removal of KD-CIF activity in KCM with the exclusion of
factors between 30 and 50 kDa. On the basis of our findings,
keratinocyte-derived IL-1a and IL-1b (B18 kDa), soluble-
form TNF-a (B25 kDa), and IFN-a and IFN-b (B20 kDa) are
unlikely to be the KD-CIFs characterized in this study.
Soluble TNF-a forms a homotrimer structure of about 75 kDa
in size and would be excluded in the fractionation process by
50 kDa filter (Jones et al., 1989). In contrast to the monomeric
type I IFNs (IFN-a and IFN-b), IFN-g forms a homodimer with
a molecular weight of about 32 kDa (Pestka et al., 2004). IFN-g
has been shown to suppress the collagen synthesis by human
dermal fibroblasts, synovial fibroblast-like cells, chondro-
cytes, and rat myofibroblasts (Granstein et al., 1990).
However, it is also unlikely that the KD-CIF effect is due to
the dimeric form of IFN-g because cytokines such as IFN-g
show sensitivity to heat and pH treatment (Sareneva et al.,
1995). Collagen-inhibitory activity in KCM was not only
blocked but also increased when KCM was treated with
either 56 1C heat or acidic pH. Although the mechanism by
which heat or acidity increases the KCM collagen-suppres-
sive effect in fibroblasts is not clear at this time, we speculate
that the effects of fibrogenic factors such as TGF-b1 and IGF-1
produced by keratinocytes might have been lost owing to the
heat or acid treatment of KCM. As a result, the efficacy of KD-
CIFs that are stable under extreme conditions becomes more
pronounced in our experiment.
It is plausible that keratinocytes act indirectly by inducing
expression and the release of an autocrine anti-fibrogenic
factor from fibroblasts, which in turn will suppress collagen
production in the same cells. In fact, evidence indicates that
keratinocyte-releasable factors can inhibit the expression of
fibrogenic factors produced by fibroblasts and released into
the culture medium (Kilani et al., 2007). TGF-b1 and
connective tissue growth factor (CTGF) are fibrogenic growth
factors produced by various cells including fibroblasts in the
skin, and they play a significant role in the induction of ECM
deposition and scar formation during wound healing (Martin,
1997; Leask et al., 2002). It has been previously demon-
strated that the expression of TGF-b1 (Le Poole and Boyce,
1999; Amjad et al., 2007) and CTGF (Nowinski et al., 2002;
Khoo et al., 2006) by fibroblasts is downregulated by the
paracrine actions of keratinocytes in a skin substitute or a
co-culture model. Interestingly, higher expression of secreted
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CTGF was observed in normal and keloid fibroblasts co-
cultured with keloid keratinocytes as compared with normal
keratinocytes (Khoo et al., 2006). Although these studies did
not directly investigate collagen expression, it is plausible
that KD-CIFs characterized in this study suppress the
production of TGF-b1 or CTGF by fibroblasts and therefore
attenuate collagen induction by the same cells. Interestingly,
Nowinski et al. (2002) reported IL-1a as a major isoform of
IL-1 detectable in KCM and responsible for inhibiting the
expression of CTGF in fibroblasts. Others have reported that
IL-1b stimulates type I collagen mRNA synthesis and inhibits
type I collagen protein synthesis in dermal fibroblasts,
suggesting regulation at the post-transcriptional or transla-
tional level (Mauviel et al., 1991). As discussed earlier, the
collagen-inhibitory factor(s) released by keratinocyte in our
study was shown to be larger than 30 kDa, excluding both
isoforms of IL-1 from the KD-CIFs described here. It should be
noted that the unprocessed precursor for human IL-1 is about
31 kDa, but its role in the regulation of collagen in dermal
fibroblasts is not known at this time. Further systematic
studies are needed to address the possible role that IL-1 and
its precursor play in the regulation of collagen expression in
fibroblasts.
Differential expression of fibrogenic factors between
differentiated and un-differentiated keratinocytes has been
reported previously. It appears that the level of TGF-b1 is
gradually reduced as keratinocytes become differentiated
(Ghahary et al., 2001). On the other hand, the level of
stratifin, recently identified as an MMP-1-stimulating factor,
markedly increases during the course of keratinocyte
differentiation (Ghahary et al., 2005). For this reason, we
also evaluated the activity of KD-CIFs in KCM obtained from
differentiated keratinocytes on pro-a1(I) collagen synthesis. In
contrast to TGF-b1 and stratifin, the level of KD-CIFs in KCM
was not affected by keratinocyte differentiation. To further
confirm this finding, we also evaluated the level of
involucrin, a keratinocyte differentiation marker, in the same
samples. The result showed an increase in the level of this
factor as early as 2 days after induction of differentiation.
Notably, the KD-CIF activity of KCM was removed following
protein precipitation with 80% ammonium sulfate. It appears
that the KD-CIF(s) tertiary structure and activity were
irreversibly altered as a result of interaction with charged
salt ions and did not recover after phosphate-buffered saline
dialysis. Interestingly, the MMP-1-stimulatory effect of KCM
was not affected by precipitation at the same salt saturation
level. Testing the supernatant of ammonium sulfate precipita-
tion did not reveal any collagen-inhibitory activity, thus
excluding the possibility of a non-protein macromolecule (for
example, lipid) remaining in the supernatant fraction during
the salting-out phase.
This study therefore advances our understanding of
keratinocyte–fibroblast interaction and confirms the presence
of keratinocyte-derived factors involved in the regulation of
ECM factors such as type I collagen. Identification of anti-
fibrogenic keratinocyte-derived factors with the ability to
suppress scar formation could prove valuable in the
development of novel therapies for fibrotic disorders. Further
studies are required to identify the exact nature of KD-CIFs
and their potential role in wound healing and fibrotic
conditions.
MATERIALS AND METHODS
Cell culture
Following informed consent, skin punch biopsies were obtained
from patients undergoing elective surgery under local anesthesia.
Written informed consent was obtained from each participant, and
the study was approved by the University of British Columbia
Hospital Human Ethics Committee and conducted according to the
Declaration of Helsinki Principles. Biopsies were then collected
individually and washed five times in sterile DMEM supplemented
with antibiotic–antimycotic preparation (100Uml1 penicillin,
100mgml1 streptomycin, and 0.25mgml1 amphotericin B).
Epidermal and dermal layers were then separated by treating
samples with dispase (Roche Applied Science, Laval, QC, Canada).
Cultures of fibroblasts and keratinocytes were established as
described previously (Ghahary et al., 2000a, 2004). Fibroblasts
were grown in DMEM with 10% FBS and keratinocytes in KSFM
(Invitrogen Life Technologies, Carlsbad, CA) supplemented with
bovine pituitary extract (50 mgml1) and epidermal growth factor
(0.2 mgml1).
Keratinocyte–fibroblast co-culture system
The co-culture model is described in Ghaffari et al. (2006). In brief,
30-mm Millicell-CM (Millipore, Billerica, MA) culture plate inserts
with 0.4-mm pore size were coated with fetal bovine skin collagen
(3mgml1) overnight. Subsequently, either keratinocytes or fibro-
blasts (0.25 106) were seeded on the collagen-coated inserts with
either KSFM supplemented with bovine pituitary extract (BPE) and
epidermal growth factor or DMEM plus 10% FBS. Fibroblasts were
seeded (0.5 106) in the bottom chamber of each well of a six-well
culture plate containing DMEM with 10% FBS. Cells were incubated
for 24 hours, after which the conditioned medium was collected and
the cells were washed with phosphate-buffered saline. To assemble
the co-culture system, collagen-coated inserts with either keratino-
cytes (K/F) or fibroblasts (F/F) (upper chamber) were placed on top of
the fibroblasts (bottom chamber) in six-well plates. The test medium
used in co-culture consisted of 49% KSFM without supplements and
49% DMEM plus 2% FBS for K/F and F/F. The co-culture study was
also performed on a three-dimensional human skin equivalent.
Fibroblasts grown in collagen gel were prepared by casting 2 106
cells in 1.0ml of bovine type I procollagen as described previously
(Sarkhosh et al., 2003). After overnight incubation, 5 105
keratinocytes (K/F) or fibroblasts (F/F) were seeded on the surface
of fibroblasts in collagen gel and grown in 49% KSFM without
supplements and 49% DMEM plus 2% FBS. Fibroblasts were
harvested from the fibroblasts grown in collagen gel by digesting
the collagen lattice with bacterial collagenase (Sigma, Oakville,
Ontario, Canada) as described by Sarkhosh et al. (2003).
Treatment of fibroblasts with KCM
To collect KCM from keratinocyte culture alone, our test medium
consisted of 50% DMEM plus 50% KSFM in the absence of FBS or
growth supplements. To evaluate the effects of KCM on fibroblast
collagen type I expression, the following experiments were
performed: (1) fibroblasts were treated with KCM or fresh medium
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for up to 48 hours. (2) To examine the stability of KD-CIFs, (A) KCM
was subjected to acidic conditions (pH 2.0) for 30minutes by adding
hydrochloric acid and then neutralized back to pH 7.4 with the
addition of sodium hydroxide solution; (B) To observe the effect of
heat on the activity of KD-CIFs, samples of KCM were subjected to
56 1C for 30minutes before fibroblasts were treated; and (C) the
secreted proteins in KCM were concentrated using ammonium
sulfate precipitation. After the collection of KCM from the cells,
proteins were precipitated by the addition of ammonium sulfate at
80% saturation for 30minutes at 4 1C under slow stirring. Pre-
cipitated proteins were pelleted by centrifugation (30minutes,
3000 g at 41C) and resuspended in phosphate buffer (20mM, pH
7.2). Ammonium sulfate was removed by dialysis against the same
phosphate buffer containing 1mM dithiothreitol (DTT), overnight at
4 1C. Fibroblasts were treated with the above conditioned medium
for 24 or 48 hours in triplicate experiments. (3) To determine the
effects of keratinocyte differentiation, KCM collected from keratino-
cytes at various time points (0, 4, 8, 10, and 14 days) was examined
for collagen-inhibitory effects on fibroblasts as well as MMP-1
expression after 48 hours of treatment. Expression of a differentiation
marker (involucrin) was evaluated at the same time points in
keratinocyte lysate (by western analysis). The results of triplicate
experiments are presented.
Molecular weight estimation of KD-CIFs
To estimate the molecular weight of KD-CIFs, KCM was passed
through 50 and 30 kDa cutoff Centricon filters (Millipore) and
portions of total KCM, filtrate, and retentate were individually
analyzed. Each fraction was used to treat fibroblasts, and the level of
pro-a1(I) collagen was determined by northern analysis after
24 hours in duplicate experiments for each of the 50 and 30 kDa
cutoff filter products. Total KCM and NCM (medium alone) and its
fractions were also used as positive and negative controls,
respectively.
RNA isolation and northern blot analysis
Total RNA was isolated from treated cells and their controls as
previously described (Ghahary et al., 1998). Total RNA was then
separated by electrophoresis (10 mg per lane) and blotted onto a
nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA). After
2 hours incubation in prehybridization solutions, blots were hybri-
dized using type I collagen, collagenase-1 (MMP-1), or 18S
ribosomal RNA (loading control) radioisotope-labeled cDNA probes.
Autoradiography was performed by exposing a Kodak X-Omat film
to nitrocellulose filters at 201C in the presence of an intensifying
screen. The cDNA probes for pro-a1(I), MMP-1, and 18S ribosomal
RNA were obtained from the American Type Culture Collection
(Rockville, MD).
Western blot analysis
Western blot technique was carried out as previously described
(Ghaffari et al., 2006). Immunoblotting was performed with a
1:5,000 dilution of rabbit anti-human procollagen type I (Rockland,
Gilbertsville, PA), 1:2,000 dilution of mouse monoclonal anti-
involucrin (Sigma), 1:500 dilution of mouse monoclonal anti-human
MMP-1 (R&D Systems, Minneapolis, MN), or 1:20,000 dilution of
mouse anti-human b-actin mAbs (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA). The appropriate secondary antibody (horseradish
peroxidase-conjugated IgG) was used at a 1:3,000 dilution (Bio-Rad,
Mississauga, ON, Canada).
Statistical analysis
Data were expressed as mean±SD and analyzed with one-way
analysis of variance with Tukey–Kramer multiple comparison
test among different groups of each cell type where indicated.
P-values less than 0.05 are considered statistically significant in this
study.
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